Iterum Therapeutics PLC (ITRM) Live Share Price, Invest From India

Iterum Therapeutics PLC Stock Performance

as on April 1, 2026 at 6:59 am IST

Day's High
$0.03
Day's Price Range
$0.05
$0.03
66.67%
Upside
52 Week's Low
52 Week's High
$0.03
52-Week Price Range
$1.28
$0.03
9.67%
Downside
4166.67%
Upside

Iterum Therapeutics PLC share price movements today

Previous Close: $0.07
Open: $0.04
Volume: 36.7M
Day's Low - High: $0.03 - $0.05
52 Week Low - High: $0.03 - $1.28

Iterum Therapeutics PLC Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Iterum Therapeutics PLC Stock Fundamentals & Key Indicators

Check Iterum Therapeutics PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Iterum Therapeutics PLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iterum Therapeutics PLC with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Iterum Therapeutics PLC	BUY	$-	NA	NA	0.00%
Insmed Inc	BUY	$30.1B	329.05%	NA	-210.54%
Alnylam Pharmaceuticals Inc	BUY	$40.2B	127.94%	75.85	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.9B	99.08%	25.18	32.94%
Regeneron Pharmaceuticals Inc	BUY	$73.6B	40.83%	17.13	29.65%

Analyst Recommendation on Iterum Therapeutics PLC Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Iterum Therapeutics PLC. Average target price of $9

Iterum Therapeutics PLC Share Price Target

Get share price movements and forecasts by analysts on Iterum Therapeutics PLC.

What analysts predicted

99.67%UPSIDE

Target Price

Current Price

$0.03

Analyzed by

8 Analysts

Target

$9.00

Iterum Therapeutics PLC target price $9, a slight upside of 99.67% compared to current price of $0.03. According to 8 analysts rating.

Iterum Therapeutics PLC Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	2	-	-	-	-	-	-	0
Gross Profit	0	0	0	0	0	-	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-3	-12	-7	-4	-6	-6	-4	-6	-8
Net Profit Margin	0.00%	0.00%	-471.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2302.31%

Iterum Therapeutics PLC Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	0	0	-	-	-	-	-
Gross Profit	-	0	0	0	0	-2	-1	-1	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-13	-29	-77	-103	-52	-91	-44	-38	-24
Net Profit Margin	0.00%	-5788.58%	-8867.20%	-278729.73%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Iterum Therapeutics PLC

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0.02%
Newbridge Financial Services Group, Inc.	0%
Alpine Partners VI, LLC	0.02%
Two Sigma Investments LLC	0%
Renaissance Technologies Corp	1.06%

See all

Insights on Iterum Therapeutics PLC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 799.2% return, outperforming this stock by 892.2%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 112.9% return, outperforming this stock by 206.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ITRM stock has moved down by -59.1%

About Iterum Therapeutics PLC

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives. It offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The Company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Organisation	Iterum Therapeutics PLC
E-voting on shares	Click here to vote

FAQs

What is Iterum Therapeutics PLC share price today?

Iterum Therapeutics PLC share price today is $0.03 as on April 1, 2026 at 1:29 am IST at the close of the market. Iterum Therapeutics PLC share today touched a day high of $0.05 and a low of $0.03.

What is the 52 week high and 52 week low for Iterum Therapeutics PLC share?

Iterum Therapeutics PLC share touched a 52 week high of $1.28 on July 11, 2025 and a 52 week low of $0.03 on March 27, 2026. Iterum Therapeutics PLC stock price today i.e. April 1, 2026 at 1:29 am IST is closed at $0.03,which is 97.66% down from its 52 week high and 10.70% up from its 52 week low.

How to invest in Iterum Therapeutics PLC Stock (ITRM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Iterum Therapeutics PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iterum Therapeutics PLC Shares that will get you 50.0000 shares as per Iterum Therapeutics PLC share price of $0.03 per share as on April 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Iterum Therapeutics PLC Stock (ITRM) from India?

Indian investors can start investing in Iterum Therapeutics PLC (ITRM) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 5:11 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Iterum Therapeutics PLC stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 5:11 pm IST). Based on Iterum Therapeutics PLC share’s latest price of $0.03 as on April 1, 2026 at 1:29 am IST, you will get 333.3333 shares of Iterum Therapeutics PLC. Learn more about fractional shares .